Mexico Steps Up Ban On Sub-Standard Foreign Drugs

11 September 1994

With an expected influx of medicines into Mexico via the North American Free Trade Agreement, both orthodox and natural and homeopathic remedies, Mexico is stiffening its existing drug controls dating back to late November 1993. The Ministry of Health has initiated a permanent drive to seize all medicines in pharmacies, natural health and homeopathic stores where these do not have official registration for their commercialization.

Carlos Soto Castaneda, director of the Ministry's Vigilance and Sanitary Control Division, has authorized special agents not only to seize all medicines that do not comply with existing dispositions for their sale, but also to seek out those medicines from the USA and other foreign sources that do not comply with Mexican standards of quality.

The goal of the increased supervision of medicines is to further improve the existing situation in the medical field. Constant supervision is proposed on a national scale to avoid the sale of medicines which fail to guarantee their therapeutic value, or where they are not in accordance with the New Public Health Law.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight